Journal
EXPERT OPINION ON THERAPEUTIC TARGETS
Volume 18, Issue 6, Pages 651-664Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1517/14728222.2014.896903
Keywords
apoptosis; apoptosis signal-regulating kinase 1; cancer; endoplasmic reticulum stress; infection; neurodegenerative diseases; oxidative stress
Categories
Funding
- JSPS
- MEXT
- Advanced research for medical products Mining Programme of the National Institute of Biomedical Innovation
- Grants-in-Aid for Scientific Research [26114009, 20229004, 25650004] Funding Source: KAKEN
Ask authors/readers for more resources
Introduction: All organisms are ordinarily exposed to various stresses. It is important for organisms to possess appropriate stress response mechanisms and to maintain homeostasis because the disruption of a stress response system can cause various diseases. Apoptosis signal-regulating kinase 1 (ASK1) is one of the stress-responsive MAP3Ks. ASK1 plays an important role in the response to reactive oxygen species (ROS), endoplasmic reticulum stress and pro-inflammatory cytokines, and it is involved in the pathogenesis of various diseases. Areas covered: In this review, the authors describe recent literature concerning the intricate and elaborate regulation system of ASK1, the function of ASK1 during a cellular stress response and the involvement of ASK1 in many diseases, including cancer, neurodegenerative diseases, infections, diabetes and cardiovascular diseases. Expert opinion: In certain disease conditions, ASK1 plays a protective role, whereas ASK1 can exacerbate the pathology of other diseases. Although ASK1 is involved in various diseases, there is no therapy or drug that targets ASK1 for use in a clinical setting. Recently, ASK1 inhibitors (K811 and MSC2032964A) have emerged, and their therapeutic potentials have been tested in vivo. ASK1 is currently receiving considerable attention as a new therapeutic target.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available